{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:41:45Z","timestamp":1758588105204,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.transproceed.2019.03.060","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T17:18:35Z","timestamp":1563902315000},"page":"2637-2642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term Survival Analysis of Kidney Transplant Recipients Receiving Mizoribine as a Maintenance Immunosuppressant: A Single-Center Study"],"prefix":"10.1016","volume":"51","author":[{"given":"Dongyeol","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Yeoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Hun","family":"Sin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Seok","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.03.060_bib1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1172\/JCI115101","article-title":"Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine","volume":"87","author":"Turka","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.transproceed.2019.03.060_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1620\/tjem.205.87","article-title":"Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome","volume":"205","author":"Tanaka","year":"2005","journal-title":"The Tohoku J Exp Med"},{"key":"10.1016\/j.transproceed.2019.03.060_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1442-200X.2006.02178.x","article-title":"High-dose mizoribine treatment for adolescents with systemic lupus erythematosus","volume":"48","author":"Nozu","year":"2006","journal-title":"Pediatr Int"},{"key":"10.1016\/j.transproceed.2019.03.060_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1328-8067.2002.01536.x","article-title":"Mizoribine: mode of action and effects in clinical use","volume":"44","author":"Yokota","year":"2002","journal-title":"Pediatr Int"},{"key":"10.1016\/j.transproceed.2019.03.060_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1432-2277.2005.00093.x","article-title":"Immunosuppressive efficacy of mycophenolate mofetil when compared with azathioprine and mizoribine against peripheral lymphocytes from renal transplant recipients","volume":"18","author":"Sugiyama","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2019.03.060_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.transproceed.2011.11.020","article-title":"Experiences of high-dose mizoribine as antimetabolite immunosuppressants for kidney transplantation","volume":"44","author":"Nakamura","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.03.060_bib7","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.transproceed.2013.03.016","article-title":"A\u00a0Japanese multicenter study of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroid in renal transplantation (the fourth report)","volume":"45","author":"Oshiro","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.03.060_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.transproceed.2011.12.009","article-title":"The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment","volume":"44","author":"Yoshimura","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.03.060_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.transproceed.2012.12.028","article-title":"Mizoribine versus mycophenolate mofetil in combination therapy with tacrolimus for de novo kidney transplantation: evaluation of efficacy and safety","volume":"45","author":"Ju","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.03.060_bib10","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/S0041-1345(99)00599-0","article-title":"Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression","volume":"31","author":"Tanabe","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.03.060_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.clinbiochem.2014.01.014","article-title":"Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation---a meta-analysis","volume":"47","author":"Xing","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.transproceed.2019.03.060_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.transproceed.2016.10.018","article-title":"Comparison of mizoribine and mycophenolate mofetil with a tacrolimus-based immunosuppressive regimen in living-donor kidney transplantation recipients: a retrospective study in China","volume":"49","author":"Shi","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.03.060_bib13","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1016\/j.transproceed.2018.01.059","article-title":"Conversion from mycophenolates to mizoribine is associated with lower BK virus load in kidney transplant recipients: a prospective study","volume":"50","author":"Yuan","year":"2018","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519302830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519302830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:31:25Z","timestamp":1758576685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519302830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0041134519302830"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.03.060","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Survival Analysis of Kidney Transplant Recipients Receiving Mizoribine as a Maintenance Immunosuppressant: A Single-Center Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.03.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}